REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Cefarm Rzeszow S.A. (Poland)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Cefarm Rzeszow S.A. Profile Updated: March 21, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Cefarm Rzeszow S.A. is a nationwide distributor of pharmaceuticals, which in addition to the sale of pharmaceuticals, is engaged in the provision of logistics services to producers in the pharmaceutical industry. The company provides services for pharmacies, pharmacy chains, hospitals, pharmaceutical wholesalers, manufacturers.

Headquarters
Ul. Krzemieniecka 60A
Wroclaw; Dolnoslaskie; Postal Code: 54-613

Contact Details: Purchase the Cefarm Rzeszow S.A. report to view the information.

Website: http://cefarmrzeszow.pl/

Basic Information
Total Employees:
Purchase the Cefarm Rzeszow S.A. report to view the information.
Outstanding Shares:
Purchase the Cefarm Rzeszow S.A. report to view the information.
Registered Capital:
Purchase the Cefarm Rzeszow S.A. report to view the information.
Financial Auditors:
Purchase the Cefarm Rzeszow S.A. report to view the information.
Incorporation Date:
March 27, 2001
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Company Performance
Financial values in the chart are available after Cefarm Rzeszow S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
16.18%▲
Total operating revenue
15.26%▲
Operating profit (EBIT)
-6.33%▼
EBITDA
11.85%▲
Net Profit (Loss) for the Period
N/A
Total assets
10.94%▲
Total equity
-3.07%▼
Operating Profit Margin (ROS)
0.14%▲
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-1.87%▼
Cash Ratio
-0.02%▼

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo